Jorgensen Biotech Consulting ApS: Financial statements 2024
CVR: 42981761
Source: annual report 2024, Danish Business Authority
01/07/2023 – 30/06/2024
Jorgensen Biotech Consulting ApS (CVR 42981761) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 2,388,009 and a net result of DKK 246,920. Equity in the 2024 report amounted to DKK 361,418. The solvency ratio was 27.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 2,388,009
- Profit/Loss
- DKK 246,920
- Equity
- DKK 361,418
- Total Assets
- DKK 1,322,095
- Employees
- 1
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout Jorgensen Biotech Consulting ApS
Jorgensen Biotech Consulting ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2022. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Kjærsgaard Jørgensen. The company is owned by JoBiCo Holding ApS. The company has 2 employees (2026). In 2026, the company reported a gross profit of DKK 3,669,337 and a net result of DKK 462,628 compared with DKK -373,758 the year before. Equity in the 2026 report amounted to DKK 328,288.
